242-243 / 2953
Long term risks of IMRT in paediatric setting are not
quantified
An inability to deliver dose to the PTV in high-risk
neuroblastoma could impact on local control and possibly
survival
Conclusions
Dose escalation to gross residual disease unlikely to be
possible with conventional techniques
Essential that we prospectively evaluate new radiotherapy
techniques in the paediatric group